Cannatonic | Cannabis Strain Review & Effects
MK Ultra x G13 Haze
Cannatonic is a hybrid strain (MK Ultra x G13 Haze) with THC levels of 6-17%. It features a Myrcene-dominant terpene profile and is known for relaxed and uplifted. Best used during any time of day.
THC
6-17%
CBD
6-17%
Best Time
Primary Effects
Flavor Notes
Earthy, Citrus, Pine, Herbal
Aroma
Earthy aroma with citrus and pine notes
Research Sources
29 peer-reviewed studies
Verified Via
PubMed / DOI
Evidence
Research-Backed
Updated
December 2025
What is Cannatonic?
Cannatonic is a hybrid strain (MK Ultra x G13 Haze) with THC levels of 6-17%. It features a Myrcene-dominant terpene profile and is known for relaxed and uplifted. Best used during any time of day.
About Cannatonic Strain
Cannatonic is a balanced hybrid cannabis strain created by crossing MK Ultra x G13 Haze, bred by Resin Seeds. With THC levels around 6-17%, Cannatonic provides a gentler experience that may be more approachable for some users. Notably, this strain also contains 6-17% CBD, making it a balanced option for therapeutic use.
Users of Cannatonic commonly report feeling relaxed, uplifted, happy, focused. The effects provide a balanced experience, starting with gentle mental stimulation before transitioning into full-body relaxation. This makes Cannatonic versatile for various situations and times of day. Thanks to its balanced effects, this strain can be enjoyed at any time of day depending on your tolerance and needs.
Medical cannabis patients frequently turn to Cannatonic for relief from chronic pain, anxiety, muscle spasms, seizures, migraines. Myrcene, the dominant terpene, is associated with sedative and muscle-relaxant properties that may enhance the strain's therapeutic potential.
Cannatonic is considered beginner-friendly, making it accessible for those new to cannabis or with lower tolerance levels. Start with a small dose and wait at least 15-30 minutes before consuming more, especially when trying this strain for the first time. Common side effects may include dry mouth. Staying well-hydrated and having snacks on hand can help minimize discomfort.
The aroma of Cannatonic is characterized by earthy, citrus, pine notes that create a distinctive sensory profile. On the palate, expect earthy, citrus, pine flavors that develop throughout each session. The myrcene-dominant terpene profile is largely responsible for these aromatic and flavor characteristics, contributing to the entourage effect that shapes the overall experience.
Related Reading
Commonly Used For
Patients often seek Cannatonic for relief from the following conditions:
Note: These are commonly reported uses based on patient experiences. Individual results may vary. Always consult with a healthcare provider to determine if medical cannabis is appropriate for your specific condition.
Potential Side Effects
Be aware of these commonly reported side effects when using Cannatonic:
How to minimize side effects
- Start with a low dose, especially if new to cannabis
- Stay hydrated before, during, and after use
- Use in a comfortable, familiar environment
- Avoid mixing with alcohol or other substances
Terpene Profile
Primary research: Anti-inflammatory
Concentration Levels
Cannabinoid Profile
Therapeutic Profile Matches
Based on Cannatonic's terpene and cannabinoid profile, it may be well-suited for these therapeutic applications:
muscle spasms
- High myrcene content supports muscle spasms & spasticity
- High beta-caryophyllene content supports muscle spasms & spasticity
- balanced ratio matches profile
chronic pain
- High myrcene content supports chronic pain
- balanced ratio matches profile
- balanced ratio matches profile
multiple sclerosis
- High myrcene content supports multiple sclerosis
- balanced ratio matches profile
- balanced ratio matches profile
migraines
- High myrcene content supports migraines & headaches
- balanced ratio matches profile
- Best used anytime, aligning with condition needs
ptsd
- High myrcene content supports ptsd & trauma
- High beta-caryophyllene content supports ptsd & trauma
- balanced ratio matches profile
Match scores are theoretical
These scores are based on terpene/cannabinoid research and do not guarantee specific effects. Individual responses vary significantly. Always consult a healthcare provider.
- 1
Surendran S, et al. Myrcene—What Are the Potential Health Benefits of This Flavouring and Aroma Agent? Frontiers in Nutrition. 2021
Comprehensive review: β-myrcene may potentiate the anti-nociceptive properties of cannabinoids.
- 2
Sewell RA, et al. The Effects of β-myrcene on Simulated Driving Cannabis and Cannabinoid Research. 2023
Found myrcene alone did not significantly impair simulated driving performance.
- 3
do Vale TG, et al. Sedative effects of myrcene in mice Phytomedicine. 2002
Demonstrated dose-dependent sedative and motor-relaxant effects in mice.
- 4
Lorenzetti BB, et al. Anti-inflammatory activity of myrcene Journal of Ethnopharmacology. 1991
Found peripheral analgesic activity in animal models.
- 5
Rao VS, et al. Antinociceptive action of myrcene Journal of Pharmacy and Pharmacology. 1990
Investigated pain-modulating mechanisms in animal studies.
- 6
Lee GY, et al. Alpha-pinene enhances memory via acetylcholinesterase inhibition Dementia and Geriatric Cognitive Disorders. 2017
α-Pinene inhibited AChE and improved memory in mice.
- 7
Falk AA, et al. Bronchodilator effects of α-pinene Xenobiotica. 1990
α-Pinene showed bronchodilator activity in humans.
- 8
Nam SY, et al. Anti-inflammatory and anti-allergic activities of α-pinene Phytotherapy Research. 2014
α-Pinene reduced IgE-mediated allergic inflammation.
- 9
Salehi B, et al. Biological activities of α-pinene: A comprehensive review Biomolecules. 2019
Most comprehensive review of pinene pharmacology.
- 10
Gertsch J, et al. β-Caryophyllene is a dietary cannabinoid Proceedings of the National Academy of Sciences. 2008
Landmark paper: BCP directly activates CB2 receptors.
- 11
Klauke AL, et al. β-Caryophyllene reduces neuropathic pain via CB2 and PPAR-γ European Journal of Pain. 2014
Showed dual mechanism for neuropathic pain relief.
- 12
Bahi A, et al. Anxiolytic-like effect of β-caryophyllene Physiology & Behavior. 2014
BCP reduced anxiety via CB2 receptor activation.
- 13
Horvath B, et al. Anti-inflammatory effects of β-caryophyllene Free Radical Biology and Medicine. 2012
BCP reduced inflammation markers and oxidative stress.
- 14
Tambe Y, et al. Gastroprotective effects of β-caryophyllene Planta Medica. 1996
BCP protected gastric mucosa in ulcer models.
- 15
Gaoni Y, Mechoulam R. Isolation, structure, and partial synthesis of an active constituent of hashish Journal of the American Chemical Society. 1964. doi:10.1021/ja01062a046
Landmark paper first identifying and synthesizing THC.
- 16
Whiting PF, et al. Cannabinoids for medical use: A systematic review and meta-analysis JAMA. 2015
Comprehensive review finding moderate evidence for chronic pain.
- 17
Aviram J, Samuelly-Leichtag G. Cannabinoids for neuropathic pain Journal of Pain Research. 2017
Review of clinical trials for neuropathic pain.
- 18
Lutge EE, et al. Dronabinol for AIDS-related anorexia Cochrane Database of Systematic Reviews. 2013
Systematic review of appetite stimulation evidence.
- 19
Smith LA, et al. Cannabinoids for chemotherapy-induced nausea and vomiting Cochrane Database of Systematic Reviews. 2015
High-quality evidence for CINV efficacy.
- 20
Kesner AJ, Lovinger DM. Cannabis, cannabinoids, and sleep Neuropsychopharmacology. 2020
Review of THC effects on sleep architecture.
- 21
Novotna A, et al. Nabiximols for spasticity in multiple sclerosis European Journal of Neurology. 2011
Phase III trial showing efficacy for MS spasticity.
- 22
Silvestro S, et al. Therapeutic potential of cannabidiol (CBD) Journal of Cellular Physiology. 2020
Comprehensive review of CBD's therapeutic applications.
- 23
Devinsky O, et al. Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome New England Journal of Medicine. 2018
Phase III trial leading to FDA approval of Epidiolex.
- 24
Devinsky O, et al. Cannabidiol for treatment-resistant epilepsy Lancet Neurology. 2016
Open-label trial showing 36.5% reduction in seizures.
- 25
Shannon S, et al. Cannabidiol in anxiety and sleep: A large case series Permanente Journal. 2019
79.2% of patients reported reduced anxiety within first month.
- 26
Bergamaschi MM, et al. CBD reduces anxiety in social anxiety disorder Neuropsychopharmacology. 2011
CBD reduced anxiety in simulated public speaking test.
- 27
Burstein S. Cannabidiol as an emergent therapeutic strategy for reducing inflammation Bioorganic & Medicinal Chemistry. 2015
Review of CBD's anti-inflammatory mechanisms.
- 28
Shannon S, et al. Cannabidiol for treatment of insomnia Permanente Journal. 2019
66.7% of patients reported improved sleep.
- 29
Boyaji S, et al. Cannabidiol for chronic pain management Current Opinion in Anesthesiology. 2020
Review of CBD's analgesic mechanisms.
Research Verification
All citations link directly to PubMed or the original source. You can verify any claim by clicking the reference link. Learn more about how we research.
Frequently Asked Questions
What are the effects of Cannatonic?
Cannatonic is known for producing relaxed, uplifted, happy, focused effects. As a hybrid, it's typically best suited for anytime use. This strain is considered beginner-friendly.
What conditions might Cannatonic help with?
Cannatonic is commonly used by patients seeking relief from chronic pain, anxiety, muscle spasms, seizures, migraines. Always consult with a healthcare provider before using cannabis for medical purposes.
What does Cannatonic taste and smell like?
Cannatonic features earthy, citrus, pine flavors with a earthy, citrus, pine aroma. Its unique terpene combination creates a memorable sensory experience.
What are the side effects of Cannatonic?
Common side effects include dry mouth. Staying hydrated and starting with a low dose can help minimize these effects.
Is Cannatonic good for medical use?
With 6-17% CBD content, Cannatonic is popular among medical cannabis patients. The balanced cannabinoid profile may provide therapeutic benefits with reduced psychoactive effects. Always consult with a healthcare provider.
Quick Facts
- Type
- Hybrid
- Genetics
- MK Ultra x G13 Haze
- Breeder
- Resin Seeds
- Genetic Family
- Haze Family
- Best Time of Use
- Any Time
- Availability
- common
- Grow Difficulty
- moderate
- Experience Level
- Beginner Friendly
Dominant Terpene
Myrcene
Earthy, musky, clove-like
Want to try Cannatonic? Get your medical marijuana card today.
Get Your CardSimilar Strains
If you like Cannatonic, try these
Related by Genetics
Educational Information
This content is for educational purposes only and is not medical advice. Consult a healthcare provider before using cannabis products.
Strain Variability
Profiles vary between batches, growers, and growing conditions. Always check lab test results for the specific product you're purchasing.
Beyond Indica/Sativa
Effects are better predicted by cannabinoid and terpene profiles than strain classification. Focus on the chemistry, not the label.
Understanding Therapeutic Profiles
Learn how terpenes and cannabinoids work together to create each strain's unique effects and therapeutic potential through the entourage effect.
Learn About Therapeutic Profiles